Induction treatment with alemtuzumab combined with polychemotherapy containing Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) followed by Alemtuzumab maintenance in patients with T-Cell prolymphocytic leukaemia (T-PLL): first analysis of a prospective multicenter phase-II-trial (T-PLL2) conducted by the German CLL study group (GCLLSG)
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Article (Journal) Conference Paper |
| Language: | English |
| Published: |
2014
|
| In: |
Blood
Year: 2014, Volume: 124, Issue: 21 |
| ISSN: | 1528-0020 |
| Online Access: | Verlag, kostenfrei, Volltext: https://ashpublications.org/blood/article/124/21/1999/89928/Induction-Treatment-with-Alemtuzumab-Combined-with
|
| Author Notes: | Natali Pflug, Georg Hopfinger, Paula Cramer, Alexandra Schrader, Nicole Weit, Rita Meister, Miriam Thiel, Tanja Annolleck, Anne Westermann, Till M Seiler, Thorsten Zenz, Jan Duerig, Jasmin Bahlo, Karl-Anton Kreuzer, Stephan Stilgenbauer, Anna-Maria Fink, Barbara Eichhorst, Michael Hallek, Marco Herling |
| Item Description: | Gesehen am 09.07.2015 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1528-0020 |